Latest Share Chat

REMOVE ADS

VEC.L Share News (VEC)

VEC.L Information

There is currently no data for VEC

REMOVE ADS

VEC.L News

Friday broker round-up UPDATE

Aggreko: Berenberg initiates with a target price of 2010p and a hold recommendation. APR Energy: Berenberg starts with a target price of 610p and a s...

Tuesday broker round-up - UPDATE

Aveva Group: UBS raises target price from 1740p to 1810p and downgrades from neutral to sell. Balfour Beatty: Berenberg downgrades from buy to hold. ...

Vectura director exercises options after milestone payment

Shares of Cambridge-based Vectura rose after it confirmed the Japanese government has approved its Seebri inhalation capsules used in inhaler devices....

Japan approves Vectura's inhaler capsules

Shares of Cambridge-based Vectura rose after it confirmed the Japanese government has approved its Seebri inhalation capsules used in inhaler devices....

Vectura reaches new milestone in VR315 project

Vectura Group, a pharma company specialising in treatments for respiratory diseases, has recorded revenues of three million dollars under an agreement...

Tuesday broker round-up

ARM Holdings: Nomura maintains neutral rating and 600p target. Associated British Foods: Nomura keeps buy stance and 1,325p target; Jefferies mains h...

Drug trial success boosts Vectura

Vectura, the pharma company specialising in treatments for respiratory diseases, says a trial of one of its development drugs has shown better results...

Vectura study reaches end point of third phase of study

Drug developer Vectura has announced that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) al...